AgingResearch.News
Frontiers in Cardiovascular Medicine

Ultra-early in-cath lab evolocumab achieves rapid lipid target attainment and lipid quality improvement in acute coronary syndrome: a real-world propensity score-matched study

By Yufeng Jiang, Jie Lin, Mingyu Ma, Show 3 more authorsPujiao Yu
Study in peopleInterventions
Paper

The paper

Yufeng Jiang, Jie Lin, Mingyu Ma, Show 3 more authorsPujiao Yu

Shanghai University of Medicine and Health Sciences

Frontiers in Cardiovascular Medicine, 22 Jul 2026

doi.org/10.3389/fcvm.2026.1860137PubMed 42558689

Related